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Background: In the general population, most individuals with mental disorders are not treated with psychotropic medications. The
objective of this study was to identify factors associated with psychotropic medication use over a 17 year period in a birth cohort.
Method: Members of the 1946 British birth cohort (n=2928 in 1999) reported psychotropic medication use in 1982 at age 36, in
1989 at age 43, and in 1999 at age 53. At each of the three time points, several factors were investigated for their association with
antidepressant, anxiolytic or hypnotic medication use.
Results: After adjusting for severity of symptoms of depression and anxiety, clinical factors such as suicidal ideation, sleep
difficulty and poor physical health were strongly associated with antidepressant, anxiolytic or hypnotic medication use in 1982 and
1989, but not in 1999. Non-clinical factors were infrequently associated with antidepressant, anxiolytic or hypnotic medication use
in 1982 and 1989 after adjusting for severity of symptoms, however several non-clinical factors were associated with
antidepressant, anxiolytic or hypnotic medication use in 1999 including being female (OR=1.4, 95% CI: 1.0, 1.9), unemployment
(OR=2.9, 95% CI: 2.1, 4.1), living alone (OR=2.6, 95% CI: 1.7, 3.9), and being divorced, separated or widowed (OR=1.5, 95%
CI: 1.1, 2.3).
Limitations: Data were not available on help-seeking behaviour.
Conclusions: Treatment of mental disorder with psychotropic medications is strongly associated with clinical factors. However,
non-clinical factors continue to be significant, and may influence both treatment-seeking and prescribing behaviour.
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Open access under CC BY license. 1. Introduction
Epidemiological studies in the U.S. and Europe
(Burns et al., 2003; Colman et al., 2006; Linden et al.,
1999; Simon et al., 2004; Spijker et al., 2001) have
shown that the majority of individuals suffering from
depression and similar common mental disorders do not
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with psychotropic medications range from 23 to 43%
(Colman et al., 2006; Linden et al., 1999; Spijker et al.,
2001). The 1997 U.S. National Depressive and Manic-
Depressive Association Consensus Statement on the Un-
dertreatment ofDepression concluded that a pertinent area
of research is identifying patient-related factors that con-
tribute to undertreatment (Hirschfeld et al., 1997).
Clinical characteristics such as severity of current
symptoms and a history of mental illness have been
consistently linked to help-seeking behaviour and treat-
ment with psychotropic medications among those with
depression. For example, severity of symptoms (Andrews
et al., 2001; Bebbington et al., 2000; Burns et al., 2003;
Linden et al., 1999; Mojtabai et al., 2002; Simon et al.,
2004; Spijker et al., 2001), suicidal ideation (Burns et al.,
2003; Mojtabai et al., 2002), duration of illness
(Blumenthal and Endicott, 1996; Spijker et al., 2001),
and a history of psychiatric treatment (Blumenthal and
Endicott, 1996; Burns et al., 2003) have been linked to
treatment formental illness. However, non-clinical factors
have also been shown to predict treatment, and may be
more strongly associated with treatment than clinical
factors (Linden et al., 1999; Simon et al., 2004).
For example, many studies have shown that women
(Andrews et al., 2001; Bebbington et al., 2000; Linden
et al., 1999; Mojtabai et al., 2002) and those who are
divorced, separated or widowed (Andrews et al., 2001;
Bebbington et al., 2000; Linden et al., 1999; Mojtabai
et al., 2002), unemployed (Bebbington et al., 2000;
Linden et al., 1999; Spijker et al., 2001) or highly
educated (Andrews et al., 2001; Blumenthal and
Endicott, 1996) are all more likely to seek and receive
treatment for common mental disorders.
To date, little research has examined whether the
predictive nature of these factors has changed over time.
The objective of this study was to identify factors as-
sociated with antidepressant, anxiolytic or hypnotic use
during three assessments over a 17-year period, and to
describe changes in the predictive nature of these fac-
tors over time. We hypothesized that, given efforts to
educate the British population about depression such as
the “Defeat Depression Campaign” (Paykel et al., 1998)
and the proliferation of clinical guidelines that might
standardize care such as the National Institute for Clini-
cal Excellence Clinical Guideline for Management of
Depression in Primary and Secondary Care (National
Institute for Clinical Excellence, 2004), non-clinical
factors such as sociodemographics, personality and socio-
economic characteristics would be less important in more
recent assessments, after adjusting for severity of psy-
chiatric symptoms.2. Method
2.1. Subjects
Subjects were members of the Medical Research
Council National Survey of Health and Development
(NSHD). This is a longitudinal study of 5362 indivi-
duals born in England, Scotland, or Wales, during the
week of March 3–9, 1946. The sample has been pro-
spectively studied on 21 occasions up to age 53. Com-
parisons with census data show that those remaining in
the cohort (n=3673 at age 53) are broadly representative
of all native-born adults currently resident in Great
Britain (Wadsworth et al., 2003).
This paper reports on data collected at three oc-
casions: in 1982 at age 36 (n=3248), in 1989 at age 43
(n=3197), and in 1999 at age 53 (n=2928).
2.2. Antidepressant, anxiolytic and hypnotic use
Survey members reported prescription medication
use to a nurse interviewer in 1982, 1989 and 1999.
Medications were then matched to a British National
Formulary Volume 44 (BNF) code by a trained research
nurse.Medications described in this report are: hypnotics
(Section 4.1.1 of the BNF), anxiolytics (Section 4.1.2 of
the BNF), and antidepressants (Section 4.3 of the BNF).
As the focus of our analysis was treatment of common
psychiatric symptoms, we excluded individuals who
reported use of antipsychotics (Sections 4.2.1 and 4.2.2
of the BNF) or mood stabilizers (Section 4.2.3 of the
BNF) in 1982, 1989 or 1999 (n=52).
2.3. Predictors of antidepressant, anxiolytic and hypnotic
use
Numerous factors were considered for possible
associations with treatment with psychotropic medica-
tions. First was the presence of mental disorder. Ad-
ditional predictors can be broadly grouped into clinical
and non-clinical characteristics. Among the clinical
characteristics, both current clinical features and psy-
chiatric history were considered. Among non-clinical
characteristics, personality, social and related factors,
and factors describing the survey member's parents and
childhood were considered.
2.3.1. Mental disorder
Survey members were considered to have mental
disorder in 1982 if they scored 5 or higher on the In-
dex of Definition of the Present State Examination (PSE;
Wing et al., 1978), yielding a prevalence of 5.9%. This
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43 and 53 (Colman et al., 2006). Consequently, sur-
vey members were considered to have mental disorder
in 1989 if they scored 31 or higher on the Psychiat-
ric Symptom Frequency scale (PSF; Lindelow et al.,
1997), and were considered to have mental disorder in
1999 if they scored 12 or higher on 28-item General
Health Questionnaire (GHQ; Goldberg and Hillier,
1979).
2.3.2. Current clinical features
Three current clinical characteristics were consid-
ered: suicidal ideation, sleep difficulty, and poor phy-
sical health. Survey members were considered to have
suicidal ideation in 1982 if they reported during the PSE
they had “deliberately considered suicide”, in 1989 if
they reported during the PSF they had “thought about
taking their own life”, and in 1999 if they “definitely
thought about making away with themselves” or
“definitely found that the idea of taking their life kept
coming into their minds”. Survey members were con-
sidered to have trouble sleeping if they answered
positively to any question regarding sleep difficulties
on the PSE or GHQ in 1982 and 1999, respectively, and
if they reported trouble sleeping in 1989. Finally, survey
members were considered to be in poor physical health
if they did not report feeling “physically very fit” on the
PSE or GHQ in 1982 and 1999, respectively.
2.3.3. Psychiatric history
Four variables were used to assess the psychiatric
history: adolescent mental disorder, psychiatric treat-
ment between age 16 and 36, self-reported history of
nervous trouble and previous psychotropic medication
use.
Survey members were assessed to have adolescent
mental disorder based on based on questionnaires
completed by teachers when the survey members were
13 and 15 years of age. These questionnaires have
previously been subjected to factor analysis, with one
factor being identified as anxious and depressive symp-
toms (Colman et al., 2007).
NSHD staff has previously used in- and out-patient
hospital records and contact with physicians to assess
whether a survey member had psychiatric treatment
between the ages of 16 and 36 (Paykel et al., 2006).
Survey members reported if they had ever suffered
from “nervous trouble” in 1982 and 1989. Survey mem-
bers were considered to have previous psychotropic
medication use if they had reported psychotropic
medication use in a postal questionnaire in 1977, or
used psychotropic medications in 1982 or 1989.2.3.4. Personality
Neurotic and extravert personality traits were mea-
sured using the Maudsley Personality Inventory at age
16 (Eysenck, 1958). Individuals were considered to have
high neuroticism or extraversion if they scored 7 or
higher on a scale from 0 to 12.
2.3.5. Social and related factors
Survey members were asked to report on a number of
general sociodemographic factors in 1982, 1989 and
1999, including their employment status, their marital
status, and whether they lived alone. Social class was
based on the British Registrar General's social class
classification according to the current or last occupation
of the survey member (Kuh et al., 2005); members were
grouped into manual vs. non-manual social classes.
Highest level of education was measured based on
examination reports and by self-report at age 26. Survey
members were grouped into those with ‘ordinary’
qualifications (O-levels or lower) or ‘advanced’ quali-
fications (A-levels or higher) (Richards et al., 2001).
In 1982, survey members reported the occurrence
of eight stressful life events (SLEs) in the previous
12 months, while in 1989 and 1999 the occurrence of 17
SLEs in the previous 12 months were recorded (van Os
et al., 2001). Survey members were grouped into those
who had one or no SLEs in the previous year versus
those with more. In addition, the sex of the survey
member was included in this section.
2.3.6. Parental and childhood factors
In 1989, survey members were asked if either of their
parents had trouble with their nerves. This retrospective
measure was used in all three sub-samples.
Survey members' cognitive ability was measured
at age 8 using reading comprehension, word pronun-
ciation, vocabulary, and non-verbal reasoning tests.
These test scores have been combined to create a glob-
al cognitive ability (Richards et al., 2001). Survey mem-
bers were grouped according to whether they were above
(i.e., high cognitive ability) or below the median on this
composite score. In addition, the social class of the father
as described above was included in this section.
2.4. Statistical analysis
The predictors listed above were tested for their
association with drug treatment in 1982, 1989 and 1999
using logistic regression. All predictive factors, apart
from mental disorder, were tested for their association
with drug treatment after controlling for severity of
psychiatric symptoms using the continuous scores (i.e.,
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age 43, and GHQ score at age 53). Associations are
presented as odds ratios (ORs) with 95% confidence
intervals (95% CI).
3. Results
In 1982, at age 36, 145 individuals (4.5%) were using
an antidepressant, anxiolytic or hypnotic. In 1989, at age
43, 144 individuals (4.5%) were using one of these
psychotropic medications. In 1999, at age 53, 174 in-
dividuals (5.9%) were using an antidepressant, anxio-
lytic or hypnotic.
3.1. Clinical predictors of antidepressant, anxiolytic or
hypnotic use
The presence of mental disorder was strongly
associated with the likelihood of using an antidepres-
sant, anxiolytic or hypnotic in 1982, 1989 and 1999 (see
Table 1). In addition, suicidal ideation, sleep difficulties,
and poor physical health were all associated with drug
treatment after adjusting for severity of symptoms in
1982 and 1989, but not in 1999.
A history of psychiatric symptoms or treatment was
also strongly associated with the likelihood of being
treated with an antidepressant, anxiolytic or hypnotic
(see Table 1). Previous psychotropic medication use was
a consistent predictor of current use. Similarly, psychia-
tric treatment during early adulthood was associated
with psychotropic medication use. In addition, a self-Table 1





Mental disorder 9.1 (6.2, 13
Current clinical symptoms
Current suicidal ideation 3.1 (1.4, 7.2
Current sleep troubles 1.8 (1.2, 2.8
Currently in poor physical health 1.7 (1.2, 2.5
Previous psychiatric history
Adolescent mental disorder 1.2 (0.7, 2.4
Treatment for psychiatric illness ages 16 to 36 2.8 (1.8, 4.4
Self-reported history of nervous trouble 7.3 (4.8, 11
Previous psychotropic medication use 7.7 (4.5, 13
Odds ratios in bold are significant at pb0.05.
a Odds ratios for all variables, apart from mental disorder, are adjusted foreported history of nervous trouble was also associated
with medication use.
3.2. Non-clinical predictors of antidepressant, anxiolytic
or hypnotic use
Non-clinical characteristics were less consistently
associated with antidepressant, anxiolytic or hypnotic
use, after controlling for severity of psychiatric
symptoms (see Table 2). In 1982, unemployed and
less neurotic individuals were more likely to be using
psychotropic medications. In 1989, females and those
whose parents had nervous trouble were more likely to
be using psychotropic medications. Several non-clinical
factors were associated with antidepressant, anxiolytic
or hypnotic use in 1999. Females and those whose
parents had nervous trouble were again more likely to be
using psychotropic medications, as were those who
were neurotic, living alone, unemployed, and divorced,
separated or widowed.
4. Discussion
4.1. The findings and existing research
Contrary to our original hypothesis, clinical pre-
dictors were less likely to be associated with the use of
antidepressants, anxiolytics or hypnotics in 1999 as
compared with 1982 or 1989. For example, suicidal
ideation, difficulty sleeping, and poor physical health
were associated with psychotropic medication use inepisode of mental disorder
or treatment (95% CI) a
1989 1999
Age 43 Age 53
n=3197 n=2928
.4) 11.9 (8.1, 17.3) 7.8 (5.4, 11.4)
) 2.8 (1.4, 5.6) 0.8 (0.2, 3.4)
) 5.0 (3.4, 7.4) 0.8 (0.5, 1.3)
) n/a 0.8 (0.5, 1.2)
) 1.4 (0.7, 2.7) 1.6 (0.9, 3.0)
) 2.1 (1.3, 3.5) 3.5 (2.2, 5.3)
.0) 6.5 (4.3, 9.9) n/a
.4) 5.5 (3.5, 8.6) 6.4 (4.4, 9.4)
r severity of symptoms of mental disorder.
Table 2
Non-clinical predictors of those treated with psychotropic medications during an episode of mental disorder, adjusted for severity of mental disorder
and previous psychotropic medication use
Odd ratios for treatment (95% CI) a
1982 1989 1999
Age 36 Age 43 Age 53
n=3248 n=3197 n=2928
Personality
High neuroticism 0.6 (0.4, 0.9) 1.1 (0.7, 1.6) 1.5 (1.1, 2.2)
High extraversion 0.9 (0.6, 1.4) 0.7 (0.5, 1.0) 1.0 (0.7, 1.4)
Social and related factors
Female 1.2 (0.8, 1.7) 1.5 (1.1, 2.2) 1.4 (1.0, 1.9)
Currently in manual social class 0.9 (0.6, 1.4) 1.0 (0.7, 1.5) 1.0 (0.7, 1.5)
Completed A-levels 0.8 (0.6, 1.2) 1.0 (0.7, 1.5) 0.8 (0.6, 1.2)
Divorced, separated, or widowed 1.6 (0.9, 2.6) 1.0 (0.6, 1.6) 1.5 (1.1, 2.3)
Currently living alone 0.8 (0.3, 2.0) 1.2 (0.6, 2.2) 2.6 (1.7, 3.9)
Current unemployment 1.9 (1.2, 3.2) 1.3 (0.6, 2.9) 2.9 (2.1, 4.1)
More than 1 stressful life event in past year 1.0 (0.7, 1.4) 1.0 (0.7, 1.5) 1.1 (0.8, 1.5)
Parental and childhood factors
Father was manual social class 1.0 (0.7, 1.5) 0.9 (0.6, 1.3) 1.0 (0.7, 1.4)
Parents had nervous trouble 0.8 (0.5, 1.2) 1.5 (1.0, 2.3) 1.6 (1.1, 2.4)
Low cognitive ability 1.0 (0.7, 1.5) 1.0 (0.7, 1.5) 1.1 (0.8, 1.5)
Odds ratios in bold are significant at pb0.05.
a Odds ratios for all variables are adjusted for severity of symptoms of mental disorder.
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associated with psychotropic drug use in 1999. On the
other hand, non-clinical factors were more likely to be
associated with antidepressant, anxiolytic or hypnotic
use in 1999 than in 1982 or 1989, after adjusting for
severity of psychiatric symptoms.
One of the factors very strongly associated with
antidepressant, anxiolytic and hypnotic use in this study
was the individual reporting a history of nervous
trouble. An important aspect of this variable is that
individuals who report a history of nervous trouble are
acknowledging that they have had problems with mental
health. Those with mental health difficulties are not
always likely to acknowledge current or present symp-
toms; among NSHD survey members who had mental
disorder in adolescence, the majority do not report a
history of nervous trouble as little as ten years later
(Colman et al., 2007). One of the key barriers to treat-
ment of depression is whether an individual recognises
the fact that they have an illness (Docherty, 1997). This
is related to the concept of perceived need for treatment.
Psychological models of perceived need identify three
stages that an individual goes through before perceiving
a need for treatment: experiencing symptoms, evaluat-
ing the significance of these symptoms and possible
consequences, and determining whether treatment may
be beneficial (Mojtabai et al., 2002). Perceived need forcare is strongly associated with help-seeking behaviour
for those with symptoms of mental illness (Andrews
et al., 2001; Burns et al., 2003; Mojtabai et al., 2002).
Another strong predictor of antidepressant, anxiolytic
and hypnotic use was having employed similar strategies
to deal with mental illness in the past. These variables
comprise two factors: a past psychiatric history, and a
demonstrated willingness to seek and receive treatment.
Having a positive attitude towardsmental health treatment
is associatedwith help-seeking behaviour (Mojtabai et al.,
2002); if patients have demonstrated a previous positive
attitude towards mental health treatment then they are
likely to use future treatment. However, among indivi-
duals who recognise that they could benefit from help
with their mental health, many do not seek or choose to
accept any form of treatment (Andrews et al., 2001;
Mojtabai et al., 2002). Many prefer to manage on their
own (Andrews et al., 2001; Blumenthal and Endicott,
1996; Burns et al., 2003), or depend upon friends or
family for help (Burns et al., 2003). This may be because
individuals are embarrassed or afraid to speak to a health
professional about their mental health (Blumenthal and
Endicott, 1996; Simon et al., 2004), or fear possible
consequences in their career or personal relationships
(Blumenthal and Endicott, 1996; Simon et al., 2004).
It is notable that non-clinical factors like unemploy-
ment and lack of social support were associated with
239I. Colman et al. / Journal of Affective Disorders 110 (2008) 234–240antidepressant, anxiolytic and hypnotic use in 1999,
which may reflect physician behaviour or attitudes to
their patient's social and economic situations. This may
be particularly relevant when social or occupational
influences have been present for some time (e.g., un-
employment), and thought to influence the persistence
of the episode or prognosis of the illness. Since many
cases of depression remit spontaneously regardless of
treatment (Simon et al., 1999), physicians may choose to
not treat a proportion of patients, expecting the symp-
toms to subside naturally. A recent British study re-
ported that physicians' preferred strategy for dealing
with depression in primary care is to ‘wait and see’ if
symptoms remit without treatment (Hyde et al., 2005).
This strategy is most likely in cases where symptoms are
milder and of lesser duration. However, physicians may
be less likely to delay treatment in certain contexts where
consequences of non-treatment may be more severe such
as unemployment.
It is also notable that females were more likely to be
using antidepressants, anxiolytics or hypnotics in 1989
and 1999. It has been shown that females are more likely
to perceive a need for help when they have symptoms of
mental disorder (Mojtabai et al., 2002), and conse-
quently they are more likely to seek treatment for these
symptoms (Andrews et al., 2001; Bebbington et al.,
2000). Similarly, those whose parents had trouble with
nerves were more likely to be using antidepressants,
anxiolytics or hypnotics in 1989 and 1999. It has been
suggested that these individuals may be more likely to
recognize symptoms of mental illness and may be more
likely to then seek help (Mojtabai et al., 2002). Indi-
viduals whose parents have a history of mental illness
may also have witnessed successful psychiatric treat-
ment for their parents, which could positively influence
their decision to seek help.
The fact that the factors most strongly associated
with antidepressant, anxiolytic and hypnotic use were
clinical ones is a positive finding. It is, however, some-
what disconcerting that there were several non-clinical
factors associated with psychotropic medication use in
1999, particularly if these were influenced by physician
behaviour. As one commentator has observed, “The
appropriateness of current psychotropic drug prescrib-
ing practices has been repeatedly questioned. The
importance of non-clinical factors in drug prescribing
is one major source of concern.” (Linden et al., 1999) To
that end, we support those who have called for better
education of general practitioners in how to deal with
patients with psychiatric symptoms (Andrews et al.,
2001; Bebbington et al., 2000; Linden et al., 1999). A
notable study in Sweden reported that an educationprogram supporting comprehensive care for depression
by general practitioners significantly reduced rates of in-
patient treatment of depression and significantly re-
duced rates of suicide (Rutz, 2001).
With regards to treatment-seeking behaviour, many
have noted that the majority of those with mental disorder
do not seek treatment for their symptoms (Andrews et al.,
2001; Bebbington et al., 2000; Blumenthal and Endicott,
1996; Colman et al., 2006). To help improve this number,
we support efforts such as the Defeat Depression
Campaign (Paykel et al., 1998) and those who call for
further attempts to educate the public about mental illness
and appropriate treatment (Andrews et al., 2001;
Bebbington et al., 2000).
4.2. Methodological considerations
A notable limitation of this study is that the outcome,
treatment with psychotropic medications, is influenced
by two key players: patients, who must recognize their
symptoms and decide whether to seek treatment, and
physicians, who must diagnose a mental illness decide
whether or not to prescribe psychotropic drugs. It is
possible that factors that influence patient behaviour are
different from those that influence physician behaviour.
Data was available in this cohort on treatment-seeking
behaviour in this cohort in 1982 and 1989 in the form
of the question “have you visited a physician in the
past year for treatment for nerves” (data not shown).
Analysis of these data indicated that there were few
differences between predictors of treatment-seeking be-
haviour and predictors among drug treatment among
those who sought treatment.
The second limitation is that it is not possible to
separate age and period effects in this cohort study. While
we conclude that observed changes in the predictive
nature of clinical and non-clinical factors with regards to
antidepressant, anxiolytic and hypnotic use are a result of
period effects over a seventeen-year period, it may be that
these changes are a result of shifts in physician and pa-
tient behaviour as individuals age from early- to mid-
adulthood. We believe this is unlikely, given that the time
period from age 36 to 53 is not a time of great change
relative to other stages of the life course, but it is possible.
These limitations are offset by some notable strengths
of the study. First, we used data collected at three dif-
ferent time points over a 17-year period. Second, we had
a large sample size at each collection point that was
drawn from a population-based cohort. Finally, we report
on a large number of individual factors that have been
posited to be associated with psychotropic medication
use.
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Treatment of mental disorder with psychotropic medi-
cations at the population level is strongly predicted by
clinical factors. However non-clinical factors continue to
be important and may influence both treatment-seeking
and prescribing behaviour. The results support improved
education concerning treatment of common mental dis-
orders for both physicians and the public.Role of funding source
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